skip to main content

brainstorm askiatroX medicines

simulations beta

loading page…

learn & practise

exams international doctors free questions Socratic Tutor rounds stat clinical connections academy journal tool guides

clinical reference

askiatroX knowledge centre medicines UK / NICE guidance international guidance calculators q&a library

trust & support

how it works methodology account & support frequently asked questions about us clinical safety consultancy

legal

mobile app · scan to download

Medicines ethinylestradiol + norelgestrominQuestion & answer

ethinylestradiol + norelgestromin · Medicine question

Can Evra be used with glecaprevir/pibrentasvir?

iatroX medicinesPublished 8 November 2026

The answer

Answer

Evra is contraindicated with medicines containing glecaprevir/pibrentasvir.

Sources for this answer

EVRA 203 micrograms/24 hours + 33.9 micrograms/24 hours transdermal patchGedeon Richter (UK) Ltd · emc · SmPC §4.3 Contraindications · Version 3Document updated 15 May 2023

Sources checked 8 November 2026

Explore this learning need in CPDTake this topic to CPD, then choose your learning context and available question library.

The full medicine guide

More questions about ethinylestradiol + norelgestromin

What is the Evra contraceptive patch used for?How much norelgestromin and ethinylestradiol does an Evra patch release on average over 24 hours?In which age group have the safety and efficacy of Evra been established?Is Evra contraindicated in women with hepatic impairment?Is Evra indicated for use during pregnancy?What does the Evra transdermal patch look like?

ethinylestradiol + norelgestromin

Read the wider context, including uses, precautions and the sources behind this medicine guide.

Read the ethinylestradiol + norelgestromin guide

More clinical questions?

Explore the tools and reference material available on iatroX.

Explore askiatroX